{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T04:00:38Z","timestamp":1720238438488},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ijcard.2016.10.018","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T16:44:02Z","timestamp":1476549842000},"page":"337-341","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events"],"prefix":"10.1016","volume":"225","author":[{"given":"\u00d6mer","family":"Erk\u00fcner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Claessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Pisters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germaine","family":"Schulmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roos","family":"Ramaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Sonneveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elton","family":"Dudink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"Lankveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ione","family":"Limantoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bob","family":"Weijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Pison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Blaauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees B","family":"de Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry JGM","family":"Crijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijcard.2016.10.018_bb0005","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/eurheartj\/ehn139","article-title":"Prognosis, disease progression, and treatment of atrial fibrillation patients during 1year: follow-up of the Euro Heart Survey on atrial fibrillation","volume":"29","author":"Nieuwlaat","year":"2008","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2016.10.018_bb0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/europace\/eur406","article-title":"Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey","volume":"14","author":"Pisters","year":"2012","journal-title":"Europace"},{"issue":"2\u20133","key":"10.1016\/j.ijcard.2016.10.018_bb0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-5273(03)00107-4","article-title":"Atrial stunning: basics and clinical considerations","volume":"92","author":"Khan","year":"2003","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.10.018_bb0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0002-9149(69)90068-X","article-title":"The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation","volume":"23","author":"Bjerkelund","year":"1969","journal-title":"Am. J. Cardiol."},{"issue":"47","key":"10.1016\/j.ijcard.2016.10.018_bb0025","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1093\/eurheartj\/ehu367","article-title":"Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation","volume":"35","author":"Cappato","year":"2014","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ijcard.2016.10.018_bb0030","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation\u2014developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"issue":"6 Suppl","key":"10.1016\/j.ijcard.2016.10.018_bb0035","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ijcard.2016.10.018_bb0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/hrt.2004.042465","article-title":"Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population","volume":"91","author":"Jones","year":"2005","journal-title":"Heart"},{"issue":"21","key":"10.1016\/j.ijcard.2016.10.018_bb0045","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2016.10.018_bb0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review","volume":"1","author":"Wan","year":"2008","journal-title":"Circ. Cardiovasc. Qual. Outcomes."},{"issue":"2","key":"10.1016\/j.ijcard.2016.10.018_bb0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/clc.4960290209","article-title":"Rapid achievement of therapeutic anticoagulation positively affects outcome in patients undergoing cardioversion for persistent atrial fibrillation","volume":"29","author":"Cutro","year":"2006","journal-title":"Clin. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcard.2016.10.018_bb0060","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0002-9149(01)02128-2","article-title":"Time course and frequency of subtherapeutic anticoagulation for newly prescribed warfarin anticoagulation before elective cardioversion of atrial fibrillation or flutter","volume":"88","author":"Kim","year":"2001","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2016.10.018_bb0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2796.2003.01084.x","article-title":"Duration of warfarin sodium therapy prior to electrical cardioversion of atrial fibrillation","volume":"253","author":"Ryman","year":"2003","journal-title":"J. Intern. Med."},{"issue":"23","key":"10.1016\/j.ijcard.2016.10.018_bb0070","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ijcard.2016.10.018_bb0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3949\/ccjm.69.9.713","article-title":"The ACUTE trial. Transesophageal echocardiography to guide electrical cardioversion in atrial fibrillation. Assessment of cardioversion using transesophageal echocardiography","volume":"69","author":"Asher","year":"2002","journal-title":"Cleve. Clin. J. Med."},{"issue":"10 Pt 1","key":"10.1016\/j.ijcard.2016.10.018_bb0080","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0002-9149(88)91210-6","article-title":"Doppler echocardiographic predictors of recurrence of atrial fibrillation after cardioversion","volume":"62","author":"Dethy","year":"1988","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.10.018_bb0085","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ahj.2005.07.011","article-title":"Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6months: a randomized controlled trial","volume":"151","author":"Klein","year":"2006","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2016.10.018_bb0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2141.2004.05348.x","article-title":"Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism","volume":"128","author":"Veeger","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.ijcard.2016.10.018_bb0095","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ijcard.2016.10.018_bb0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.110.977546","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion","volume":"123","author":"Nagarakanti","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.10.018_bb0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.17987\/icfj.v4i0.148","article-title":"Clinical experience of dabigatran and rivaroxaban in electrical cardioversion of atrial fibrillation","volume":"4","author":"Coquard","year":"2015","journal-title":"Int. Cardiovasc. Forum J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316328200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316328200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T16:52:08Z","timestamp":1536339128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316328200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":21,"alternative-id":["S0167527316328200"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.10.018","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}